S1 Data - by Richard Junior Zapata Dongo (17912565)

Subjects:

Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Verification of PLUS CYCLE^® signals during presumed sleep periods. by Akihiro Ohnishi (10989900)

Subjects:

Expression and correlation analysis of 20 DESRGs. by Wei He (131453)

Subjects:

Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of female and male <i>M. marinus</i> (col. 1 & 2) and <i>G. pulex</i> (col. 3 & 4). by Charlotte N. Underwood (5043110)

Subjects:

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

Subjects:

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

Subjects:

The characteristics of patient groups were used to prove the method’s applicability. by Ewa Paszkowska (21246702)

Subjects:

HRV Values. by Burhan Demirkıran (21601740)

Subjects:

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

Subjects:

The observed MRM reactions. by Ewa Paszkowska (21246702)

Subjects:

ROS, K⁺ efflux and cathepsin B are required for NLRP3 activation. by Madhusoodhanan Suresh Kumar Meena Kumari (20896666)

Subjects:

Diagnostic value of the 8 hub genes in the GSE52093 dataset. by Wei He (131453)

Subjects:

Comprehensive list of all SRGs. by Wei He (131453)

Subjects:

Differences in health-related quality of life indexes after disease onset between groups. by Ji Woong Chang (1829314)

Subjects:

Changes in subcutaneous fat thickness and muscle mass (Approximately here). by Burhan Demirkıran (21601740)

Subjects:

Overall comparison of <i>Anaplasma</i> spp. and <i>A. ovis</i> prevalence among the goats enrolled from three districts in Punjab during the present study. % prevalence is given in... by Sumaira Sumaira (21453523)

Subjects:

Data from qPCR analysis of eDNA and matching hemolymph timepoints. by Rachael M. Giersch (22331947)

Subjects:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

Subjects:

Intra- and inter-day precision and accuracy. by Ewa Paszkowska (21246702)

Subjects: